LANTHEUS HOLDINGS INC (LNTH) Stock Fundamental Analysis
NASDAQ:LNTH - Nasdaq - US5165441032 - Common Stock - Currency: USD
Taking everything into account, LNTH scores 7 out of 10 in our fundamental rating. LNTH was compared to 188 industry peers in the Health Care Equipment & Supplies industry. Both the health and profitability get an excellent rating, making LNTH a very profitable company, without any liquidiy or solvency issues. A decent growth rate in combination with a cheap valuation! Better keep an eye on LNTH. These ratings could make LNTH a good candidate for value and quality investing.
1. Profitability
1.1 Basic Checks
LNTH had positive earnings in the past year.
LNTH had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: LNTH reported negative net income in multiple years.
Each year in the past 5 years LNTH had a positive operating cash flow.
1.2 Ratios
With an excellent Return On Assets value of 12.37%, LNTH belongs to the best of the industry, outperforming 94.68% of the companies in the same industry.
LNTH has a better Return On Equity (21.85%) than 93.62% of its industry peers.
LNTH has a Return On Invested Capital of 18.93%. This is amongst the best in the industry. LNTH outperforms 97.34% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for LNTH is significantly above the industry average of 7.89%.
The 3 year average ROIC (16.25%) for LNTH is below the current ROIC(18.93%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 12.37% | ||
| ROE | 21.85% | ||
| ROIC | 18.93% |
ROA(3y)12.56%
ROA(5y)5.58%
ROE(3y)25.01%
ROE(5y)11.41%
ROIC(3y)16.25%
ROIC(5y)N/A
1.3 Margins
With an excellent Profit Margin value of 16.55%, LNTH belongs to the best of the industry, outperforming 93.62% of the companies in the same industry.
LNTH's Profit Margin has improved in the last couple of years.
With an excellent Operating Margin value of 29.30%, LNTH belongs to the best of the industry, outperforming 98.40% of the companies in the same industry.
LNTH's Operating Margin has improved in the last couple of years.
LNTH's Gross Margin of 64.04% is fine compared to the rest of the industry. LNTH outperforms 65.96% of its industry peers.
In the last couple of years the Gross Margin of LNTH has grown nicely.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 29.3% | ||
| PM (TTM) | 16.55% | ||
| GM | 64.04% |
OM growth 3YN/A
OM growth 5Y14.46%
PM growth 3YN/A
PM growth 5Y17.41%
GM growth 3Y13.43%
GM growth 5Y5.06%
2. Health
2.1 Basic Checks
LNTH has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
Compared to 1 year ago, LNTH has about the same amount of shares outstanding.
The number of shares outstanding for LNTH has been increased compared to 5 years ago.
LNTH has a better debt/assets ratio than last year.
2.2 Solvency
An Altman-Z score of 6.14 indicates that LNTH is not in any danger for bankruptcy at the moment.
LNTH has a Altman-Z score of 6.14. This is amongst the best in the industry. LNTH outperforms 84.04% of its industry peers.
LNTH has a debt to FCF ratio of 1.20. This is a very positive value and a sign of high solvency as it would only need 1.20 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 1.20, LNTH belongs to the top of the industry, outperforming 90.43% of the companies in the same industry.
A Debt/Equity ratio of 0.49 indicates that LNTH is not too dependend on debt financing.
LNTH has a Debt to Equity ratio (0.49) which is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.49 | ||
| Debt/FCF | 1.2 | ||
| Altman-Z | 6.14 |
ROIC/WACC2.26
WACC8.38%
2.3 Liquidity
A Current Ratio of 5.74 indicates that LNTH has no problem at all paying its short term obligations.
The Current ratio of LNTH (5.74) is better than 80.85% of its industry peers.
A Quick Ratio of 5.46 indicates that LNTH has no problem at all paying its short term obligations.
Looking at the Quick ratio, with a value of 5.46, LNTH belongs to the top of the industry, outperforming 81.91% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 5.74 | ||
| Quick Ratio | 5.46 |
3. Growth
3.1 Past
The Earnings Per Share has been growing slightly by 2.64% over the past year.
LNTH shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 42.10% yearly.
LNTH shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 12.53%.
LNTH shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 34.59% yearly.
EPS 1Y (TTM)2.64%
EPS 3Y140.07%
EPS 5Y42.1%
EPS Q2Q%-9.47%
Revenue 1Y (TTM)12.53%
Revenue growth 3Y53.37%
Revenue growth 5Y34.59%
Sales Q2Q%0.75%
3.2 Future
LNTH is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 7.20% yearly.
LNTH is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 7.69% yearly.
EPS Next Y0.63%
EPS Next 2Y5.56%
EPS Next 3Y9.03%
EPS Next 5Y7.2%
Revenue Next Year3.55%
Revenue Next 2Y6.41%
Revenue Next 3Y8.41%
Revenue Next 5Y7.69%
3.3 Evolution
The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 11.76 indicates a reasonable valuation of LNTH.
Compared to the rest of the industry, the Price/Earnings ratio of LNTH indicates a rather cheap valuation: LNTH is cheaper than 91.49% of the companies listed in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 26.31, LNTH is valued rather cheaply.
The Price/Forward Earnings ratio is 10.30, which indicates a very decent valuation of LNTH.
90.96% of the companies in the same industry are more expensive than LNTH, based on the Price/Forward Earnings ratio.
LNTH's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 22.13.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 11.76 | ||
| Fwd PE | 10.3 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, LNTH is valued cheaper than 90.96% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, LNTH is valued cheaply inside the industry as 95.21% of the companies are valued more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 11.38 | ||
| EV/EBITDA | 9.77 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates LNTH does not grow enough to justify the current Price/Earnings ratio.
The excellent profitability rating of LNTH may justify a higher PE ratio.
PEG (NY)18.63
PEG (5Y)0.28
EPS Next 2Y5.56%
EPS Next 3Y9.03%
5. Dividend
5.1 Amount
LNTH does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
77.83
-2.31 (-2.88%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners115.61%
Inst Owner Change6.19%
Ins Owners1.3%
Ins Owner Change4.04%
Market Cap5.39B
Analysts82.11
Price Target131.89 (69.46%)
Short Float %11.66%
Short Ratio7.21
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-4.03%
Min EPS beat(2)-9.67%
Max EPS beat(2)1.61%
EPS beat(4)2
Avg EPS beat(4)-1.14%
Min EPS beat(4)-9.67%
Max EPS beat(4)7.07%
EPS beat(8)6
Avg EPS beat(8)5.62%
EPS beat(12)10
Avg EPS beat(12)11.67%
EPS beat(16)14
Avg EPS beat(16)27.27%
Revenue beat(2)1
Avg Revenue beat(2)-0.72%
Min Revenue beat(2)-3.58%
Max Revenue beat(2)2.13%
Revenue beat(4)2
Avg Revenue beat(4)-0.11%
Min Revenue beat(4)-3.58%
Max Revenue beat(4)2.13%
Revenue beat(8)5
Avg Revenue beat(8)1%
Revenue beat(12)9
Avg Revenue beat(12)2.39%
Revenue beat(16)13
Avg Revenue beat(16)4.62%
PT rev (1m)-4.16%
PT rev (3m)-4.05%
EPS NQ rev (1m)-0.18%
EPS NQ rev (3m)-2.25%
EPS NY rev (1m)0%
EPS NY rev (3m)-3.79%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-1.52%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-1.83%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 11.76 | ||
| Fwd PE | 10.3 | ||
| P/S | 3.5 | ||
| P/FCF | 11.38 | ||
| P/OCF | 10.26 | ||
| P/B | 4.63 | ||
| P/tB | 5.67 | ||
| EV/EBITDA | 9.77 |
EPS(TTM)6.62
EY8.51%
EPS(NY)7.55
Fwd EY9.71%
FCF(TTM)6.84
FCFY8.78%
OCF(TTM)7.59
OCFY9.75%
SpS22.21
BVpS16.83
TBVpS13.72
PEG (NY)18.63
PEG (5Y)0.28
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 12.37% | ||
| ROE | 21.85% | ||
| ROCE | 24.91% | ||
| ROIC | 18.93% | ||
| ROICexc | 39.39% | ||
| ROICexgc | 52.34% | ||
| OM | 29.3% | ||
| PM (TTM) | 16.55% | ||
| GM | 64.04% | ||
| FCFM | 30.78% |
ROA(3y)12.56%
ROA(5y)5.58%
ROE(3y)25.01%
ROE(5y)11.41%
ROIC(3y)16.25%
ROIC(5y)N/A
ROICexc(3y)32.43%
ROICexc(5y)N/A
ROICexgc(3y)46.23%
ROICexgc(5y)N/A
ROCE(3y)21.38%
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5Y26.32%
ROICexc growth 3YN/A
ROICexc growth 5Y20.97%
OM growth 3YN/A
OM growth 5Y14.46%
PM growth 3YN/A
PM growth 5Y17.41%
GM growth 3Y13.43%
GM growth 5Y5.06%
F-Score8
Asset Turnover0.75
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.49 | ||
| Debt/FCF | 1.2 | ||
| Debt/EBITDA | 1.1 | ||
| Cap/Depr | 82.91% | ||
| Cap/Sales | 3.39% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 102.34% | ||
| Profit Quality | 185.99% | ||
| Current Ratio | 5.74 | ||
| Quick Ratio | 5.46 | ||
| Altman-Z | 6.14 |
F-Score8
WACC8.38%
ROIC/WACC2.26
Cap/Depr(3y)104.83%
Cap/Depr(5y)78.74%
Cap/Sales(3y)4.75%
Cap/Sales(5y)4.15%
Profit Quality(3y)383.97%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)2.64%
EPS 3Y140.07%
EPS 5Y42.1%
EPS Q2Q%-9.47%
EPS Next Y0.63%
EPS Next 2Y5.56%
EPS Next 3Y9.03%
EPS Next 5Y7.2%
Revenue 1Y (TTM)12.53%
Revenue growth 3Y53.37%
Revenue growth 5Y34.59%
Sales Q2Q%0.75%
Revenue Next Year3.55%
Revenue Next 2Y6.41%
Revenue Next 3Y8.41%
Revenue Next 5Y7.69%
EBIT growth 1Y-5.08%
EBIT growth 3YN/A
EBIT growth 5Y54.05%
EBIT Next Year4.08%
EBIT Next 3Y11.97%
EBIT Next 5YN/A
FCF growth 1Y32.98%
FCF growth 3Y123.25%
FCF growth 5Y51.49%
OCF growth 1Y38.18%
OCF growth 3Y116.21%
OCF growth 5Y46.62%